Resultados de procura - Anton Pozniak

Limitar resultados
  1. 1
    HIV Drug Resistance — An Emerging Threat to Epidemic Control

    HIV Drug Resistance — An Emerging Threat to Epidemic Control por Chris Beyrer, Anton Pozniak

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points

    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points por Alice Raymond, Andrew Hill, Anton Pozniak

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs por Mariana S. Sousa, Anton Pozniak, Marta Boffito

    Publicado 2008
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Are new antiretroviral treatments increasing the risks of clinical obesity?

    Are new antiretroviral treatments increasing the risks of clinical obesity? por Andrew Hill, Laura Waters, Anton Pozniak

    Publicado 2019
    Ligazón do recurso
    Editorial
    Engadir a favoritos
    Gardado en:
  5. 5
    Has the time come to abandon efavirenz for first-line antiretroviral therapy?

    Has the time come to abandon efavirenz for first-line antiretroviral therapy? por François Raffi, Anton Pozniak, M A Wainberg

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    The treatment of tuberculosis in HIV-infected persons

    The treatment of tuberculosis in HIV-infected persons por Anton Pozniak, Robert F. Miller, Peter L. Ormerod

    Publicado 1999
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? por Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Publicado 2018
    Editorial
    Engadir a favoritos
    Gardado en:
  8. 8
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? por Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study

    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study por Sasikala Rajamanoharan, Nicola Low, Simon B. Jones, Anton Pozniak

    Publicado 1999
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Rapidly declining HIV infection in MSM in central London

    Rapidly declining HIV infection in MSM in central London por Nneka Nwokolo, Andrew Hill, Alan McOwan, Anton Pozniak

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Gonorrhoea in inner London: results of a cross sectional study

    Gonorrhoea in inner London: results of a cross sectional study por Nicola Low, Gavin Daker‐White, David H. Barlow, Anton Pozniak

    Publicado 1997
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics

    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics por Fraser Lewis, G. Hughes, Andrew Rambaut, Anton Pozniak, Andrew Brown

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP por Victoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo, Anton Pozniak

    Publicado 2018
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology por Julia del Amo, Adam S. Malin, Anton Pozniak, Kevin M. De Cock

    Publicado 1999
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Clinical management of tuberculosis and HIV-1 co-infection

    Clinical management of tuberculosis and HIV-1 co-infection por Charlotte Schutz, Graeme Meintjes, Fahad Almajid, Robert J. Wilkinson, Anton Pozniak

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance

    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance por John Walsh, Anton Pozniak, Mark Nelson, Sundhiya Mandalia, Brian George Gazzard

    Publicado 2002
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis

    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis por Christos Michailidis, Anton Pozniak, Sundhiya Mandalia, Sheena Basnayake, Mark Nelson, Brian Gazzard

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades por Jacob Levi, Alice Raymond, Anton Pozniak, Pietro Vernazza, Philipp Köhler, Andrew Hill

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy

    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy por Nathan Ford, Zara Shubber, Anton Pozniak, Marco Vitória, Meg Doherty, Catherine Kirby, Alexandra Calmy

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load por Heather Donaghy, Anton Pozniak, Brian Gazzard, Nad A. Qazi, Jill Gilmour, Frances Gotch, Steven Patterson

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: